Results 1 to 10 of about 209 (199)

Unveiling patenting strategies of therapeutics and vaccines: evergreening in the context of COVID-19 pandemic

open access: yesFrontiers in Medicine, 2023
In the pharmaceutical sector, evergreening is considered a range of practices applied to extend monopoly protection on existing products. Filing several patent applications related to the same active pharmaceutical ingredient (API) is one of the most ...
Gabriela Costa Chaves
exaly   +3 more sources

A bibliometric review of evergreening loans literature: An analysis of scopus-indexed publications

open access: yesDiscover Sustainability
This paper employs a comprehensive bibliometric approach to analyse the growth trajectory, publication patterns, journals, global author distribution, scientific output, and thematic focus within the field of evergreening loans.
Mohammad Q. M. Momani
exaly   +2 more sources

Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States: the potential effects of evergreening

open access: yesFrontiers in Psychiatry
IntroductionCitalopram and escitalopram are among the most used medications and are key treatments for many psychiatric disorders. Previous findings suggest citalopram and escitalopram prescription rates are changing because of the patent for citalopram ...
Brian Piper, Luke Cavanah
exaly   +3 more sources

LESSONS FOR THE SADC FROM THE INDIAN CASE OF NOVARTIS AG V UNION OF INDIA [PDF]

open access: yesPotchefstroom Electronic Law Journal, 2015
In the pharmaceutical context, many Southern African Development Community (SADC) members grant patents on drugs without substantially reviewing applications first, thus routinely granting patents for new versions of old medicines, thus extending patent ...
Lonias Ndlovu
doaj   +1 more source

Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products? [PDF]

open access: yesPLoS ONE, 2016
BACKGROUND:Not all new drug products are truly new. Some are the result of marginal innovation and incremental patenting of existing products, but in such a way that confers no major therapeutic improvement.
Reed F Beall   +3 more
doaj   +1 more source

The forgotten half? Women in the forest management and development discourse in Africa: A review

open access: yesFrontiers in Forests and Global Change, 2022
Numerous theoretical and empirical studies examining women's engagement in sustainable forest management (SFM) have shown that women bring distinctive interests and values to forest management.
Lalisa A. Duguma   +6 more
doaj   +1 more source

Patented drug extension strategies on healthcare spending: a cost-evaluation analysis. [PDF]

open access: yesPLoS Medicine, 2013
BACKGROUND: Drug manufacturers have developed "evergreening" strategies to compete with generic medication after patent termination. These include marketing of slightly modified follow-on drugs. We aimed to estimate the financial impact of these drugs on
Nathalie Vernaz   +8 more
doaj   +1 more source

Crystallography of Contemporary Contact Insecticides

open access: yesInsects, 2022
The active forms of contact insecticides used for combatting mosquito-borne infectious diseases are typically crystalline solids. Numerous molecular crystals are polymorphic, crystallizing in several solid forms characterized by different physicochemical
Bryan Erriah   +5 more
doaj   +1 more source

A quantitative appraisal of selected agroforestry studies in the Sub-Saharan Africa

open access: yesHeliyon, 2022
The multiple ecosystem services and livelihood assets development challenges facing the world, including climate change, land degradation, and high poverty levels, have necessitated cross-cutting solutions.
Kennedy Muthee   +5 more
doaj   +1 more source

Patents associated with high-cost drugs in Australia. [PDF]

open access: yesPLoS ONE, 2013
Australia, like most countries, faces high and rapidly-rising drug costs. There are longstanding concerns about pharmaceutical companies inappropriately extending their monopoly position by "evergreening" blockbuster drugs, through misuse of the patent ...
Andrew F Christie   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy